“…We now report the presence of GLUT4 and Kv1.3, centrally, co-localized in the mitral cell layer of the OB. Moreover, using a heterologous expression system (HEK 293 cells), we are able to increase the translocation of GLUT4 when the pore of Kv1.3 (Delaney et al, 2014 ) is mutated to yield a non-conducting channel. This suggests that a number of modulators of Kv1.3 that can inhibit channel conductance (src, EGF, insulin, BDNF, glp-1, Nedd4-2) (Holmes et al, 1996 ; Bowlby et al, 1997 ; Fadool et al, 1997 , 2000 ; Fadool and Levitan, 1998 ; Cook and Fadool, 2002 ; Colley et al, 2009 ; Thiebaud et al, 2016 ; Velez et al, 2016 ), could be poised to increase GLUT4 translocation and the utilization of glucose by mitral cells of the OB.…”